| abstract |
Quinoline and quinoxaline derivatives as protein tyrosine kinase inhibitors The present invention relates to compounds of formula (I) wherein the substituents are as defined in the specification, in free form or in the form of a pharmaceutically acceptable salt, solvate, ester, n-oxide thereof; processes for their preparation; to pharmaceutical products containing such compounds, in particular for use in one or more protein tyrosine kinase mediated diseases. |